跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOOTRENEW - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FOOTRENEW
Authorized
STANDARD
FOOTRENEW
nailrenew corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
68b2c99316c115e2
Company
nailrenew corp.
Type
Standard
Approval Details
Approval Id
68b2c99316c115e2
Drug Approval Canada Name
FOOTRENEW
Product Name
FOOTRENEW
Status
Marketed
Status Date
2023-06-01
Original Market Date
2023-06-01
Din
02527723
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:04.08.40
Atc Original
D01AE18 TOLNAFTATE
Atc Name
d 01 ae 18
Aig Number
0102537001
Company Name
nailrenew corp.
Company Address
95 Croton Lake Road, Katonah, New York, United States, 10536
Active Ingredients
TOLNAFTATE
1 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
68b2c99316c115e2
Type
Standard
Back to Health Canada Approvals